Stock Price
71.22
Daily Change
1.86 2.68%
Monthly
-1.04%
Yearly
105.25%
Q3 Forecast
68.78

Corcept Therapeutics reported $167.76M in Operating Expenses for its fiscal quarter ending in June of 2025.




Operating Expenses Change Date
Acadia Pharmaceuticals USD 232.19M 7.16M Jun/2025
Alaunos Therapeutics USD 759K 391K Dec/2024
ANI Pharmaceuticals USD 196.2M 25.27M Jun/2025
Ardelyx USD 112.06M 4.06M Jun/2025
Aurora Cannabis CAD 118.24M 66.26M Jun/2025
BioMarin Pharmaceutical USD 548.52M 27.27M Jun/2025
Bristol-Myers Squibb USD 8.5B 265M Jun/2025
Canopy Growth CAD 94.22M 4.36M Jun/2025
Corcept Therapeutics USD 167.76M 13.96M Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
J&J USD 16.8B 8.54B Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Merck USD 9.44B 217M Jun/2025
Novartis USD 9.97B 1.02B Jun/2025
Novartis USD 9.37B 782M Jun/2025
Pacira USD 170.87M 3.93M Jun/2025
Pfizer USD 11.62B 1.58B Jun/2025
Supernus Pharmaceuticals USD 153.31M 892K Jun/2025
TG Therapeutics USD 106.3M 5.93M Jun/2025